Suppr超能文献

整块切除治疗侵犯邻近器官的肝细胞癌的结果。

Results of en bloc resection for hepatocellular carcinoma extending to adjacent organs.

机构信息

Department of Hepato-Biliary-Pancreato-Vascular Surgery, First Affiliated Hospital of Xiamen University, Xiamen, China.

出版信息

Can J Surg. 2012 Aug;55(4):222-6. doi: 10.1503/cjs.028410.

Abstract

BACKGROUND

To curatively resect hepatocellular carcinoma (HCC) with adjacent organ extension, the combined resection of these organs is inevitable. We analyzed the safety and effectiveness of en bloc resection for HCC extending to adjacent organs.

METHODS

From December 2002 to May 2006, we compared the surgical outcomes of patients with HCC extending to adjacent organs with those of closely matched, randomly selected patients with HCC without adjacent organ extension.

RESULTS

We included 42 patients whose HCC extended to adjacent organs and 126 patients whose HCC did not extend to adjacent organs. There was no significant difference in survival, operative morbidity or mortality between the groups. In patients with HCC extending to adjacent organs, histopathological examination of the specimen revealed true tumour invasion in 13 and adhesion in 29 patients. Those with tumour invasion were more likely to have a high incidence of capsule infiltration, microvascular invasion and early intrahepatic recurrence (≤ 1 yr after hepatectomy). The 5-year overall survival of patients with tumour invasion was 11.5%, whereas that of patients with tumour adhesion was 38.1% (p = 0.033).

CONCLUSION

En bloc resection is a safe and effective therapy for HCC extending to adjacent organs. Tumour invasion to adjacent organs exhibits a more aggressive clinical behaviour and is associated with worse survival than tumour adhesion.

摘要

背景

为了根治性切除肝癌(HCC)伴邻近器官侵犯,联合切除这些器官是不可避免的。我们分析了整块切除侵犯邻近器官的 HCC 的安全性和有效性。

方法

从 2002 年 12 月至 2006 年 5 月,我们比较了 HCC 侵犯邻近器官的患者与邻近器官无侵犯、随机选择的 HCC 患者的手术结果。

结果

我们纳入了 42 例 HCC 侵犯邻近器官的患者和 126 例 HCC 无邻近器官侵犯的患者。两组患者的生存率、手术发病率或死亡率无显著差异。在 HCC 侵犯邻近器官的患者中,13 例标本的组织病理学检查显示真正的肿瘤侵犯,29 例为粘连。肿瘤侵犯的患者更有可能出现包膜浸润、微血管侵犯和早期肝内复发(肝切除后 1 年内)的发生率较高。肿瘤侵犯患者的 5 年总生存率为 11.5%,而肿瘤粘连患者的 5 年总生存率为 38.1%(p = 0.033)。

结论

整块切除是治疗 HCC 侵犯邻近器官的一种安全有效的方法。肿瘤侵犯邻近器官表现出更具侵袭性的临床行为,与肿瘤粘连相比,其生存预后更差。

相似文献

引用本文的文献

5
Primary hepatic carcinosarcoma with multimodal treatment.原发性肝肉瘤样癌的多模式治疗
Nagoya J Med Sci. 2018 Aug;80(3):423-429. doi: 10.18999/nagjms.80.3.423.

本文引用的文献

4
Sorafenib in advanced hepatocellular carcinoma.索拉非尼用于晚期肝细胞癌
N Engl J Med. 2008 Jul 24;359(4):378-90. doi: 10.1056/NEJMoa0708857.
6
10
Hepatocellular carcinoma: current surgical management.肝细胞癌:当前的外科治疗方法
Gastroenterology. 2004 Nov;127(5 Suppl 1):S248-60. doi: 10.1053/j.gastro.2004.09.039.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验